Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

5 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	55,410	80,154	119,069	142,148	167,671	210,240	361,599	633,797
EBITDA	5,384	13,191	-108,178	15,454	15,968	33,148	101,456	253,500
Net profit	3,478	15,885	15,552	3,395	19,255	36,575	98,603	245,515
Total assets	69,813	106,177	141,626	159,400	198,689	228,155	415,964	719,918
n (companies reporting)	1	3	3	3	4	4	5	5

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Abulpharm	—	—	—	—	—	—	134,251	341,277
Pharmed	—	10,442	25,264	34,615	41,986	60,617	57,984	79,521
GlobalPharm	55,410	60,687	60,917	60,656	74,810	72,147	70,611	74,077
Berlin-Chemie / A. Mena…	—	9,025	32,888	46,877	50,100	43,284	50,523	72,981
CIS Pharma	—	—	—	—	775	34,191	48,230	65,941

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Peer coverage varies by year — FY2017–FY2022 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.